Department of Surgery, Michigan State University, College of Human Medicine, Grand Rapids, Michigan.
Department of Research Spectrum Health, Grand Rapids, Michigan.
Ann Thorac Surg. 2020 Aug;110(2):508-515. doi: 10.1016/j.athoracsur.2019.10.075. Epub 2019 Dec 20.
The objective of this study was to compare long-term outcomes of Mosaic (Medtronic, Minneapolis, MN) porcine mitral valves to Carpentier-Edwards (Edwards Lifesciences, Irving, CA) bovine pericardial mitral valves.
From 2001 through 2017 at a single institution, 940 patients received a mitral bioprosthesis, of which 463 (49.3%) were porcine and 477 (50.7%) were bovine pericardial. Retrospective review of the procedure and the postoperative clinical course, including echocardiography, through August 2018 were analyzed. All consecutive mitral valve replacements over the study period were included. Follow-up was 99% (929 patients) complete for a total of 6045 patient-years (mean, 6.4 ± 4.5 years). A propensity-matched cohort of 802 mitral bioprosthesis was used for outcome analyses.
Operative mortality of the 940 patients was 5.4% (n = 51) and incidence of postoperative stroke was 2.1% (n = 20). Overall survival of the propensity-matched patients at 10 and 15 years was 49.7% (95% confidence interval [CI] 45.5%-53.7%) and 23.3% (95% CI 17.9%-29.3%), respectively. Survival at 15 years was 24.0% (95% CI 18.0%-30.5%) for porcine and 16.5% (95% CI 5.5%-32.6%) for bovine implants, which was not significantly different (P = .67). Overall cumulative incidence for reoperative structural valve deterioration at 15 years was 7.9% (95% CI 4.7%-12.3%) for porcine valves versus 13.2% (95% CI 8.1%-19.5%) for pericardial valves (P < .001). For patients age younger than 65 years, structural valve deterioration at 15 years was 15.8% (95% CI 7.4%-27.0%) versus 30.2% (95% CI 15.1%-46.8%) for porcine and pericardial valves, respectively (P = .009). Overall average time to reoperation for structural valve deterioration for porcine valves was 11.1 ± 2.3 years vs 6.8 ± 2.3 years for bovine pericardial valves (P < .001).
In long-term follow-up, of patients younger than 65 years of age undergoing mitral valve replacement, bovine pericardial valves experienced earlier and more frequent structural valve deterioration than porcine valves.
本研究旨在比较 Mosaic(美敦力,明尼苏达州明尼阿波利斯)猪二尖瓣与 Carpentier-Edwards(爱德华兹生命科学,欧文,加利福尼亚州)牛心包二尖瓣的长期结果。
在 2001 年至 2017 年的一家机构中,940 例患者接受了二尖瓣生物瓣置换术,其中 463 例(49.3%)为猪瓣,477 例(50.7%)为牛心包瓣。回顾性分析了手术过程和术后临床过程,包括 2018 年 8 月的超声心动图检查。本研究期间连续进行的所有二尖瓣置换术均包括在内。随访率为 99%(929 例患者),总随访时间为 6045 患者年(平均 6.4±4.5 年)。使用 802 例二尖瓣生物瓣置换术的倾向匹配队列进行了结果分析。
940 例患者的手术死亡率为 5.4%(n=51),术后卒中发生率为 2.1%(n=20)。10 年和 15 年时,倾向匹配患者的总生存率分别为 49.7%(95%置信区间[CI]45.5%-53.7%)和 23.3%(95%CI 17.9%-29.3%)。15 年时,猪瓣组的存活率为 24.0%(95%CI 18.0%-30.5%),牛心包瓣组为 16.5%(95%CI 5.5%-32.6%),两组差异无统计学意义(P=0.67)。15 年时,猪瓣组再次手术行结构性瓣膜退化的累积发生率为 7.9%(95%CI 4.7%-12.3%),牛心包瓣组为 13.2%(95%CI 8.1%-19.5%)(P<0.001)。对于年龄小于 65 岁的患者,15 年时结构性瓣膜退化率为 15.8%(95%CI 7.4%-27.0%),猪瓣和牛心包瓣分别为 30.2%(95%CI 15.1%-46.8%)(P=0.009)。猪瓣再次手术治疗结构性瓣膜退化的平均时间为 11.1±2.3 年,而牛心包瓣为 6.8±2.3 年(P<0.001)。
在长期随访中,年龄小于 65 岁的二尖瓣置换术患者中,牛心包瓣发生结构性瓣膜退化的时间早于猪瓣,且更为频繁。